Usefulness of S100B Protein in Neurological Disorders

被引:1
|
作者
Yardan, Turker [1 ]
Erenler, Ali Kemal [1 ]
Baydin, Ahmet [1 ]
Aydin, Keramettin [2 ]
Cokluk, Cengiz [2 ]
机构
[1] Ondokuz Mayis Univ, Sch Med, Dept Emergency Med, Samsun, Turkey
[2] Ondokuz Mayis Univ, Sch Med, Dept Neurosurg, Samsun, Turkey
关键词
Neurological disorders; S100B protein; brain marker; NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; SERUM S-100B PROTEIN; SUBARACHNOID ANEURYSMAL HEMORRHAGE; CHRONIC-SCHIZOPHRENIC PATIENTS; AMYOTROPHIC-LATERAL-SCLEROSIS; CALCIUM-MODULATED PROTEINS; CEREBROSPINAL-FLUID; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In recent years, there has been an increased interest in the clinical use of brain markers. The S100B is a calcium-binding peptide and is used as a parameter of glial activation and/or death in many disorders of the central nervous system (CNS). It plays important roles in normal CNS development and recovery after injury. Although S100B is mainly found in astroglial and Schwann cells, it also has extracerebral sources. S100B is a useful neurobiochemical marker of brain damage such as in circulatory arrest, stroke and traumatic brain injury. S100B is also associated with neurodegenerative diseases like Alzheimer's disease or other chronic neurological diseases. Moreover, S100B may have a potential in predicting the efficiency of treatment and prognosis. In this review, an updated overview of the role of S100B in human neurological disorders is presented.
引用
收藏
页码:276 / 281
页数:6
相关论文
共 50 条
  • [1] S100B protein in neurodegenerative disorders
    Steiner, Johann
    Bogerts, Bernhard
    Schroeter, Matthias L.
    Bernstein, Hans-Gert
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1600, 8 (00): : 1948-5875
  • [2] Targeting S100B Protein as a Surrogate Biomarker and its Role in Various Neurological Disorders
    Langeh, Urvashi
    Singh, Shamsher
    CURRENT NEUROPHARMACOLOGY, 2021, 19 (02) : 265 - 277
  • [3] The usefulness of the serum s100b protein for predicting delayed neurological sequelae in acute carbon monoxide poisoning
    Park, Eunjung
    Ahn, Junghwan
    Min, Young-Gi
    Jung, Yoon-Seok
    Kim, Kyuseok
    Lee, Jisook
    Choi, Sang-cheon
    CLINICAL TOXICOLOGY, 2012, 50 (03) : 183 - 188
  • [4] Growing role of S100B protein as a putative therapeutic target for neurological- and nonneurological-disorders
    Michetti, Fabrizio
    Di Sante, Gabriele
    Clementi, Maria Elisabetta
    Sampaolese, Beatrice
    Casalbore, Patrizia
    Volonte, Cinzia
    Spica, Vincenzo Romano
    Parnigotto, Pier Paolo
    Di Liddo, Rosa
    Amadio, Susanna
    Ria, Francesco
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2021, 127 : 446 - 458
  • [5] The role of S100B protein as a potential marker in affective disorders
    Rajewska-Rager, Aleksandra
    Pawlaczyk, Magdalena
    PSYCHIATRIA POLSKA, 2016, 50 (04) : 849 - 857
  • [6] The S100B Protein in Epilepsy
    Secen, Ahmet Eren
    Akcali, Didem Tuba
    Kurt, Goekhan
    ARCHIVES OF EPILEPSY, 2023, 29 (02): : 37 - 40
  • [7] S100B protein and autoantibodies to S100B protein in diagnostics of brain damage in craniocerebral trauma in children
    Sorokina, E. G.
    Semenova, J. B.
    Granstrem, O. K.
    Karaseva, O. V.
    Meshcheryakov, S. V.
    Reutov, V. P.
    Sushkevich, G. N.
    Pinelis, V. G.
    Roshal, L. M.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2010, 110 (08) : 30 - 35
  • [8] Neurotrophic role of the protein S100B
    Gazzolo, D
    Sacchi, R
    I CONGRESSO NAZIONALE DELLA SOCIETA ITALIANA DI MEDICINA MATERNO FETALE, 2003, : 215 - 220
  • [9] S100B protein in benzodiazepine overdose
    Ambrozic, J.
    Bunc, M.
    Osredkar, J.
    Brvar, M.
    EMERGENCY MEDICINE JOURNAL, 2008, 25 (02) : 90 - 92
  • [10] Serological determination of protein S100B
    Leidel, B. A.
    Bogner, V.
    Zock, M.
    Kanz, K. -G.
    UNFALLCHIRURG, 2012, 115 (10): : 903 - 912